Johnson, Clark
2 papers on CoChatORCID 0000-0003-1782-3954
Most cited papers
- Verified
Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer’s disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial.
Burns, D. K., Alexander, R. C., Welsh-Bohmer, K. A., Culp, M., Chiang, C., O’Neil, J., Evans, R. M., Harrigan, P., Plassman, B. L., Burke, J. R., et al. (2021) · The Lancet Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 130
- Verified
Neurocognitive effects of repetitive transcranial magnetic stimulation with a 2-coil device in treatment-resistant major depressive disorder
Kavanaugh, B. C., Aaronson, S. T., Clarke, G. N., Holtzheimer, P. E., Johnson, C. W., McDonald, W. M., Schneider, M. B., & Carpenter, L. L. (2018) · The Journal of ECT
Transcranial Magnetic Stimulation StudiesTreatment of Major Depression
Cited by 25
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free